Summary. The effects of mianserin, a tetracyclic antidepressant, and adinazolam, a new triazolobenzodiazepine which has antidepressant activity, on intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation were studied in the dog heart after myocardial infarction and compared to the effects of amitriptyline, a standard tricyclic antidepressant.
tion -Intraventricular conduction -Arrhythmia phenyl-4H-triazolo [4,3-a] [1,4]benzodiazepine methanesulfonate) (Fig. 1) . Adinazolam might have specific antidepressant activity (Pyke et al. 1983; Feighner 1986; Amsterdam et al. 1986 ). However, there have been few experimental studies on the electrophysiological effects of antidepressant agents on infarcted hearts. The present study was undertaken to examine the effects of amitriptyline, mianserin, a tetracyclic antidepressant, and adinazolam on intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation in the dog heart after myocardial infarction.
Methods and materials
(1) Animal preparation. Mongrel dogs weighing between 6.0-15.0 kg were anaesthetized with intravenously administered sodium pentobarbital, 30 mg/kg. Each animal was intubated and ventilated with room air using a positive pressure respirator. A left thoracotomy was performed in the fourth intercostal space and the heart was exposed. After opening the pericardium, the left anterior descending coronary artery was occluded by the Harris two stage procedure (Harris 1950 ) and the anterior interventricular branch was also ligated. The chest was closed immediately after the complete occlusion of the coronary artery and routine postoperative care was administered including prophylactic antibiotic therapy (daily intramuscular administration of 10 mg/kg ceftizoxime) during postinfarction convalescence.
Introduction
Overdoses of tricyclic antidepressants produce slowing of ventricular conduction and tachyarrhythmias. The wellknown potential for tricyclic antidepressants to provoke severe cardiac arrhythmias has been attributed to the direct depressant effect of these agents on intracardiac conduction (Junien et al. 1976) , as well as to enhanced myocardial catecholamine sensitivity due to inhibition of presynaptic norepinephrine re-uptake (Barth and Muscholl 1974; Barth et al. 1975) . Amitriptyline, a tricyclic antidepressant, can cause fatal cardiac arrhythmia, particularly in patients with pre-existing cardiac disease (Coull et al. 1970; Moir et al. 1972) . This has led in recent years to the development of other antidepressant agents such as tetracyclics and benzodiazepines. Adinazolam mesylate is a new triazoloberizodiazepine(8-chloro-1-[(dimethylamino)methyl]-6-Send offprint requests to M. Nishimoto at the above address (2) Measurement of ventricular delayed conduction. Seven days after the coronary occlusion, each animal was anaesthetized with sodium pentobarbital (30 mg/kg). Ventilation was performed as mentioned above, body temperature was maintained at 36-37°C, left thoracotomy was performed and the pericardium was opened. After the heart was cradled on the pericardium, a bipolar stimulating electrode was sutured on the left atrial appendage for atrial pacing, and several bipolar electrodes were sutured on the left ventricular surface of the infarcted area for recording ventricular delayed conduction. Another two bipolar electrodes were sutured on the right ventricle; one to record the conduction in the normal ventricular myocardium and the other one to produce a premature ventricular excitation by electrical stimulation of the right ventricle (Fig. 2) . Electrical stimulation of the right ventricle was made with a 5 ms rectangular pulse. Stimulus strength was kept at twice the diastolic threshold, and atrial pacing ($1) was introduced with a basic cycle length of 400 ms throughout the 24l CH3--,, °H _~N\ CH3~'±'~ --~ 2-7
• Ct--I 3S OaH Fig. 1 . Molecular structure of adinazolam mesylate electrophysiological study. In order to study the effects of drugs on ventricular conduction, conduction time of the premature ventricular excitation was measured in both normal and infarcted areas of ventricular myocardium. The time interval, ranging from the artifact of the premature stimulation to the most delayed measurable wave, was measured on epicardial bipolar electrocardiograms, and this value was estimated as the conduction time. The coupling interval of the ventricular stimulation was changed from 300 ms to 100 ms. Lead II electrocardiogram, femoral arterial pressure and epicardial bipolar electrocardiograms were recorded on the 8 channel polygraphic recorder (Nihon Kohden, Tokyo, Japan) at a paper speed of 100 mm/s.
(3) Programmed ventricular stimulation. Programmed ventricular stimulation was applied to the right ventricle using an electrical stimulator (SEN-7103; Nihon Koden, Tokyo, Japan) and a stimulus isolator (SS-102J; Nihon Koden, Tokyo, Japan). Before administering the drug, triple ventricular extra stimuli were introduced during atrial pacing at $2-$3-$4 coupling intervals beginning at 200 ms intervals and decreasing by 10 ms steps (200, 190... 150 , 140 ms) until either ventricular refractoriness, ventricular premature beat or ventricular tachycardia occurred. When these alterations occurred by the ventricular programmed stimulation, the coupling intervals were increased by 30 ms. Extra stimuli with the increased coupling intervals did not cause any ventricular arrhythmia before drug administration. After a drug was administered, extra stimuli with the same coupling intervals were introduced, and the incidence of ventricular arrhythmia was examined. Ventricular premature beat was defined as 5 or more successive ventricular beats that spontaneously reverted to normal sinus rhythm in less than 10 s. Ventricular tachycardia was considered to occur when it lasted for 10 s or more and did not terminate spontaneously.
(4) Drug administration. After control measurements were obtained, antidepressants were administered intravenously in cumulative dosages of 1, 2 and 3 mg/kg at 5 min intervals. Postdrug values were measured 5 min after administration of these drugs. The dosages of the drugs were selected according to the recommended human psychiatric dosages.
(5) Determination of myocardial infarct size. At the end of the experiment, Evans blue dye was injected into the femoral vein so that all but the coronary vascular bed perfused with the undyed blood was stained blue. Standstill was then induced by the injection of a pentobarbital overdose. The heart was rapidly removed and sectioned in transverse tings 1.0 cm thick from apex to base. The tissue slices were rinsed in cold isotonic saline and then incubated at 38°C for 20 min in a phosphate-buffered solution of triphenyltetrazolium. This produces a bright red colouration in the presence of dehydrogenase enzymes in non-infarcted myocardium, whereas infarcted regions remained unstained. The areas of infarction and non-infarction were then traced onto an acetate sheet. The drawing of the rings of myocardium were then retracted onto graph paper and the areas of total ventricle as well as of infarction were quantified by weighing.
(5) Statistical analysis. All data were expressed as arithmetic means_+ SEM. Comparison between control and drug values of epicardial conduction time were performed by analysis of variance followed by Dunnett multiple test. Chisquare analysis was used to compare the incidence of ventricular arrhythmias induced by the programmed ventricular stimulation. The criterion for statistical significance was P < 0.05.
(6) Drugs. The following drugs were used: amitriptyline hydrochloride (Triptanol, 1% solution, Merk-Banyu, Tokyo, Japan), mianserin hydrochloride (Organon, Tokyo, Japan), adinazolam (Upjohn, Tokyo, Japan). Mianserin and adinazolam were dissolved in physiological saline in the appropriate concentration.
Results

(1) The size of infarction
The size of infarction induced by the experimental procedure was 32.5 + 5.4% of the ventricle (range 26-38.2%, n = 6).
(2) Effects of antidepressants on the ventricular conduction time
Representative electrocardiograms recorded from normal and infarcted zones of ventricular myocardium are shown in Fig. 2 . L-II was standard limb II. At the basic cycle length of 400 ms, the electrocardiogram recorded from the normal zone consisted of biphasic deflection with duration of less than 50 ms, whereas most of the electrocardiograms recorded from the infarcted zone were fractionated potentials, i.e. the conduction in the infarcted zone was delayed. The delayed excitation was further delayed in the premature excitation induced by ventricular stimulation ( Fig. 3 ; black arrow), especially when the coupling interval was less than 300 ms ( Fig. 3; control) .
A typical depressive effect of amitriptyline on the delayed conduction in the infarcted zone is shown in Fig. 3 . Administration of amitriptyline prolonged the conduction time of both basic excitation and premature excitation in a dose-dependent manner in the infarcted zone (white arrows). Amitriptyline also polonged the conduction time of premature excitation in the normal zone (Fig. 3) . Figure 4 shows the changes in the conduction time of premature excitation in the infarcted and normal zones in the presence of amitriptyline. Amitriptyline at 1 mg/kg slowed ventricular conduction in a frequency-dependent manner, and at doses of 2 and 3 mg/kg significantly slowed ventricular conduction in the infarcted zone. These effects were dosedependent. Amitriptyline slowed ventricular conduction also in normal myocardium although to a lesser extent than in the infarcted myocardium. Figure 5 shows that mianserin had no significant effect on the conduction time of premature excitation in the infarcted and normal zones, Adinazolam 1-3 mg/kg failed to affect the conduction time of premature excitation in the infarcted and normal zones (Fig. 6) .
(3) Effects of antidepressants on the incidence of ventricular arrhythmia induced by programmed ventricular stimulation
The responses of antidepressants to programmed ventricular stimulation are shown in Table 1 . After administration of amitriptyline, the incidence of ventricular arrhythmias induced by programmed ventricular stimulation increased significantly.
On the other hand, 1 and 2 mg/kg mianserin caused a premature ventricular beat in only one of eight animals each, and 3 mg/kg mianserin caused ventricular tachycardia elicited by programmed ventricular stimulation in two of eight animals. 3 mg/kg adinazolam caused a premature ventricular beat in only one of eight animals. There is no statistical significance in these incidences between control and drug treatment (Table 1) .
Discussion
Tricyclic antidepressants are the most widely used agents for treatment of depressive disease. Depression frequently complicates the course of ischemic heart disease and is particularly common following myocardial infarction (Wishnie et al. 1970 ). In addition, therapeutic doses of tricyclic antidepressants can cause cardiovascular abnormalities including arrhythmias, ECG changes, orthostatic hypotension, and Fig. 4 . Effects of amitriptyline on the conduction time of premature excitation in the infarcted and normal zones in 6 animals. Amitriptyline at 1 mg/kg prolonged delayed conduction in a frequency-dependent manner, and at 2 and 3 mg/kg prolonged remarkably delayed conduction in the infarcted zone. Amitriptyline also prolonged conduction time in the normal zone. * P < 0.05; ** P < 0.01 compared with control. -k P < 0.05 compared with 300 ms coupling interval value (Marshall and Forker 1982) .
In the present study, we used a canine, seven day-post myocardial infarction model. Amitriptyline at a dose of 1 mg/kg significantly slowed ventricular conduction in a frequency-dependent manner, and at doses of 2 and 3 mg/kg significantly slowed ventricular conduction in infarcted ventricular myocardium. Ventricular conduction in normal myocardium was also significantly depressed. However, the effect of amitriptyline in normal myocardium was less pronounced than that in infarcted myocardium. Amitriptyline has frequency-dependent effects on ventricular conduction in normal dogs, with a similar time dependency to the drug's depressant effects on gmax in vitro (Nattel 1985) . These effects may contribute to the "quinidine-like" effect (Vohra et al. 1975 ). Tricyclic antidepressants have been shown to depress the rate of depolarization and prolong action potential duration of isolated cardiac fibres (Matsuo 1967) , and to slow cardiac conduction and lengthen ventricular refractory periods in anesthetized dogs (Baum et al. 1971) . In patients who developed tricyclic antidepressant-related cardiac conduction abnormalities with QRS prolongation, their proximal or AV nodal conduction was normal, while distal or VPB: ventricular premature beats, VT: ventricular tachycardia * P < 0.05; ** P < 0.01 compared with control group His-Purkinje conduction was depressed, suggesting a "quinidine-like" direct effect on the distal conduction system (Vohra et al. 1975) . The delayed conduction in myocardial infarction is one of the important mechanisms by which re-entrant ventricular arrhythmia could be induced . Since amitriptyline prolonged remarkably the delayed conduction in infarcted myocardium, it induced re-entrant ventricular arrhythmia elicited by programmed stimulation in the present experiments.
Mianserin, a novel antidepressant of tetracyclic structure, has been used to treat endogenous depressive patients . Mianserin is thought to act by blocking presynaptic alpha receptors and by increasing the turnover of noradrenaline, which contributes to the antidepressant effect (Baumann and Maitre 1977) . According to clinical reports, mianserin has few anticholinergic side effects and its cardiovascular toxicity is relatively low in healthy subjects (Burgess and Turner 1978; Coppen and Kopera 1978) and depressive patients Hopman 1980) . Many investigators have shown that mianserin does not produce any change in the QRS width (Kopera 1980; Montgomery 1983; Wester and Siegers 1980) . Mianserin produced little cardiac effects suggesting that mianserin does not have a "quinidine-like" effect on depolarization in the ventricles when taken in therapeutic doses (Edwards and Goldie 1983) . Of the three antidepressants, amitriptyline, mianserin and maprotiline (a tetracyclic antidepressant), mianserin was the least cardiotoxic in isolated hearts of rabbits (Harper and Hughes 1977) . In a previous study, we examined the haemodynamic effects of amitriptyline, mianserin and adinazolam in canine myocardial infarction. Amitriptyline produced marked depression of maximal rate of increase of left ventricular pressure, while mianserin and adinazolam produced a slight effect at clinical doses (Nishimoto et al. 1989) . In the present study, mianserin produced no significant effects on the ventricular conduction in infarcted and normal myocardium at doses of 1 -3 mg/kg, and the incidence of ventricular arrhythmia caused by mianserin was relatively lower than that caused by amitriptyline, probably because of a slight effect on the ventricular conduction. Therefore, it may be suggested that mianserin does not have a "quinidine-like" effect. These results are consistent with clinical studies.
Adinazolam is a new triazolobenzodiazepine. Adinazolam showed typical antidepressant activities in animals. Adinazolam inhibited reserpine-mediated upregulation of cortical beta adrenergic receptors in rats (Lathi et al. 1984) and sensitized forebrain hippocampal neurons to applied serotonin in rats (Turmel and de Montigny 1984) . Adinazolam might have specific antidepressant action on the core symptoms of endogenous depression (Pyke et al. 1983) . In phase II and phase III trials, adinazolam showed antidepressant activity (Feighner 1986) . Adinazolam was found to be as effective as imipramine (tricyclic antidepressant) in patients with major depression (Amsterdam et al. 1986 ). In the present study, adinazolam produced no significant effects on the ventricular conduction in infarcted and normal myocardium. Thus, adinazolam was less potent than amitriptyline in causing ventricular arrhythmia induced by programmed ventricular stimulation.
From the present results, the following may be concluded: amitriptyline in therapeutic doses markedly slowed ventricular conduction, especially in infarcted myocardium, and increased the incidence of ventricular arrhythmias induced by programmed stimulation. In contrast, mianserin and adinazolam had insignificant effects on cardiac conduction in infarcted myocardium. Considering these electrophysiological and haemodynamic effects which were previously examined (Nishimoto et al. 1989 ) mianserin and adinazolam may be recommended for depressive patients with myocardial infarction or ischaemic heart disease.
